264 related articles for article (PubMed ID: 12089289)
1. Use of the sensititre colorimetric microdilution panel for antifungal susceptibility testing of dermatophytes.
Pujol I; Capilla J; Fernández-Torres B; Ortoneda M; Guarro J
J Clin Microbiol; 2002 Jul; 40(7):2618-21. PubMed ID: 12089289
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens.
Cetinkaya Z; Kiraz N; Karaca S; Kulac M; Ciftci IH; Aktepe OC; Altindis M; Kiyildi N; Piyade M
Eur J Dermatol; 2005; 15(4):258-61. PubMed ID: 16048753
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey.
Yenişehirli G; Tunçoğlu E; Yenişehirli A; Bulut Y
Int J Dermatol; 2013 Dec; 52(12):1557-60. PubMed ID: 24134487
[TBL] [Abstract][Full Text] [Related]
4. Comparison of disk diffusion method and broth microdilution method for antifungal susceptibility testing of dermatophytes.
Esteban A; Abarca ML; Cabañes FJ
Med Mycol; 2005 Feb; 43(1):61-6. PubMed ID: 15712608
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the Sensititre YeastOne colorimetric antifungal panel with the modified Clinical and Laboratory Standards Institute broth microdilution (M38-A) method for antifungal susceptibility testing of dermatophytes.
Castro C; Serrano MC; Valverde A; Pemán J; Almeida C; Martín-Mazuelos E
Chemotherapy; 2008; 54(6):427-30. PubMed ID: 18824849
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of dermatomycoses agents to six antifungal drugs and evaluation by fractional inhibitory concentration index of combined effects of amorolfine and itraconazole in dermatophytes.
Tamura T; Asahara M; Yamamoto M; Yamaura M; Matsumura M; Goto K; Rezaei-Matehkolaei A; Mirhendi H; Makimura M; Makimura K
Microbiol Immunol; 2014 Jan; 58(1):1-8. PubMed ID: 24215461
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Sensititre YeastOne colorimetric microdilution panel and the NCCLS broth microdilution method for antifungal susceptibility testing against Candida species.
Bernal S; Aller AI; Chávez M; Valverde A; Serrano C; Gutiérrez MJ; Quindós G; Martín Mazuelos E
Chemotherapy; 2002 Mar; 48(1):21-5. PubMed ID: 11901252
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method.
Araújo CR; Miranda KC; Fernandes Ode F; Soares AJ; Silva Mdo R
Rev Inst Med Trop Sao Paulo; 2009; 51(1):9-12. PubMed ID: 19229384
[TBL] [Abstract][Full Text] [Related]
9.
Singh SK; Patwa DK; Tilak R; Das A; Singh TB
Indian J Dermatol Venereol Leprol; 2019; 85(4):388-392. PubMed ID: 30950409
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of antifungal susceptibility and keratinase, elastase, lipase and DNase activities of different dermatophyte species isolated from clinical specimens in Iran.
Sharifzadeh A; Shokri H; Khosravi AR
Mycoses; 2016 Nov; 59(11):710-719. PubMed ID: 27291045
[TBL] [Abstract][Full Text] [Related]
11. Dermatophytes growth curve and in vitro susceptibility test: a broth micro-titration method.
Alió AB; Mendoza M; Zambrano EA; Díaz E; Cavallera E
Med Mycol; 2005 Jun; 43(4):319-25. PubMed ID: 16110777
[TBL] [Abstract][Full Text] [Related]
12. [In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Serrano-Martino Mdel C; Chávez-Caballero M; Valverde-Conde A; Claro RM; Pemán J; Martín-Mazuelos E
Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):484-7. PubMed ID: 14572380
[TBL] [Abstract][Full Text] [Related]
13. A study of dermatophytes and their in-vitro antifungal sensitivity.
Sumana MN; Rajagopal V
Indian J Pathol Microbiol; 2002 Apr; 45(2):169-72. PubMed ID: 12696733
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activity of micafungin and caspofungin against dermatophytes isolated from China.
Bao YQ; Wan Z; Li RY
Mycopathologia; 2013 Feb; 175(1-2):141-5. PubMed ID: 22983900
[TBL] [Abstract][Full Text] [Related]
15. Multicenter comparison of the sensititre YeastOne Colorimetric Antifungal Panel with the National Committee for Clinical Laboratory standards M27-A reference method for testing clinical isolates of common and emerging Candida spp., Cryptococcus spp., and other yeasts and yeast-like organisms.
Espinel-Ingroff A; Pfaller M; Messer SA; Knapp CC; Killian S; Norris HA; Ghannoum MA
J Clin Microbiol; 1999 Mar; 37(3):591-5. PubMed ID: 9986817
[TBL] [Abstract][Full Text] [Related]
16. How to: perform antifungal susceptibility testing of microconidia-forming dermatophytes following the new reference EUCAST method E.Def 11.0, exemplified by Trichophyton.
Arendrup MC; Kahlmeter G; Guinea J; Meletiadis J;
Clin Microbiol Infect; 2021 Jan; 27(1):55-60. PubMed ID: 32916260
[TBL] [Abstract][Full Text] [Related]
17. In vitro evaluation of griseofulvin against clinical isolates of dermatophytes from Isfahan.
Chadeganipour M; Nilipour S; Havaei A
Mycoses; 2004 Dec; 47(11-12):503-7. PubMed ID: 15601457
[TBL] [Abstract][Full Text] [Related]
18. [Resistance to azolic compounds in clinical Trichophyton spp. strains].
Méndez-Tovar LJ; Manzano-Gayosso P; Velásquez-Hernández V; Millan-Chiu B; Hernández-Hernández F; Mondragón-González R; López-Martínez R
Rev Iberoam Micol; 2007 Dec; 24(4):320-2. PubMed ID: 18095769
[TBL] [Abstract][Full Text] [Related]
19. Dermatophyte susceptibilities to antifungal azole agents tested in vitro by broth macro and microdilution methods.
Siqueira ER; Ferreira JC; Pedroso RS; Lavrador MA; Candido RC
Rev Inst Med Trop Sao Paulo; 2008; 50(1):1-5. PubMed ID: 18327478
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of susceptibility of dermatophytes to antifungal drugs].
Macura AB; Filip E; Pawlik B
Med Dosw Mikrobiol; 1993; 45(2):253-7. PubMed ID: 8309309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
